USP28-IN-2 is a USP28 inhibitor (IC50 = 0.3 μM) with high selectivity over USP2, USP7, USP8, USP9x, UCHL3, and UCHL5; it exhibits cytotoxicity against cancer cells by downregulating c-Myc levels via the ubiquitin-proteasome system; it reduces Ankyrase-1/2 levels in vitro; and it enhances the sensitivity of colorectal cancer cells to regorafenib (HY-10331).